CYP 1.89% 27.0¢ cynata therapeutics limited

Ann: Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress, page-3

  1. 15,424 Posts.
    lightbulb Created with Sketch. 5521
    I would also say this is good news all round for CYP so it is a little puzzling that it is not Market Sensitive ? Seems like a significant update to the biggest trial CYP has been a part of so again why not mark is as market sensitive

    GLTAH
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.